DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Sportking India Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·7 Oct 2026, 9:20 am

Sportking India

Sportking India Limited has informed stock exchanges that it has obtained a certificate under SEBI's Depositories and Participants Regulations, 2018. This regulatory compliance confirms that the company meets the necessary standards to operate as a Depository Participant, a role that facilitates the electronic holding and transfer of securities.

This development is a standard corporate governance milestone for the company. It signifies that Sportking is adhering to the regulatory framework required to function as an intermediary in the securities market. For investors, this update indicates that the company is maintaining its compliance posture, which is a key factor in assessing a firm's operational health and regulatory standing.

Investors should note that this is a routine regulatory filing rather than a significant business announcement. The stock's reaction will likely depend on broader market sentiment. It is advisable to monitor the company's future quarterly results and business expansion plans to gauge the long-term impact of this compliance on its operational capabilities.